Rheumatic Heart Disease Market Report 2026

Rheumatic Heart Disease Market Overview

• Rheumatic Heart Disease market size has reached to $2.71 billion in 2025 • Expected to grow to $3.6 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Rising Prevalence of Strep Throat Driving The Growth Of The Market Due To Increasing Infection Rates And Antibiotic Resistance • Market Trend: Strengthening Healthcare Access Through Public-Private Partnerships For Early Disease Detection And Treatment • North America was the largest region in 2025.

What Is Covered Under Rheumatic Heart Disease Market?

Rheumatic heart disease (RHD) is a chronic heart condition caused by permanent damage to the heart valves due to rheumatic fever, an inflammatory disease resulting from untreated or inadequately treated streptococcal throat infections. The immune response triggered by the infection leads to inflammation and scarring of the heart valves, impairing their function and potentially causing heart failure, arrhythmias, or other complications. The main types of rheumatic heart disease include valve-related disease, myocarditis, and pericarditis. Valve-related rheumatic heart disease occurs when rheumatic fever damages the heart valves, leading to impaired blood flow and complications such as stenosis or regurgitation. The impacted age groups encompass pediatric, adolescent, adult, and geriatric populations. Rheumatic heart disease is addressed and treated across multiple applications, such as hospitals, diagnostic centers, and research centers. The distribution channels for drugs include hospital pharmacies, retail pharmacies, online pharmacies, and direct sales.

What Is The Rheumatic Heart Disease Market Growth Forecast?

The rheumatic heart disease market size is expected to see strong growth in the next few years. It will grow to $3.6 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing investments in public health screening programs, rising adoption of digital cardiac diagnostics, growing awareness of early intervention benefits, expansion of cardiac surgical infrastructure, increased focus on disease prevention strategies. Major trends in the forecast period include increasing adoption of early diagnostic screening programs, rising use of echocardiography and imaging tools, growing focus on preventive antibiotic therapies, expansion of valve repair and replacement procedures, enhanced monitoring of pediatric and adolescent patients.

Global Rheumatic Heart Disease Market Segmentation

1) By Type: Valve, Myocarditis, Pericarditis 2) By Age Group: Pediatric, Adolescent, Adult, Geriatric 3) By Application: Hospital, Diagnostic Centre, Research Centre 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales Subsegments: 1) By Valve: Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease 2) By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis 3) By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis

What Is The Driver Of The Rheumatic Heart Disease Market?

The increasing prevalence of strep throat is expected to propel the growth of the rheumatic heart disease market going forward. Strep throat refers to a bacterial infection caused by streptococcus pyogenes (group a streptococcus) it leads to inflammation and pain in the throat, often accompanied by fever, swollen lymph nodes, and difficulty swallowing. Rising antibiotic resistance is making streptococcal infections harder to treat effectively, which leads to prolonged illness and higher transmission rates in communities. Rheumatic heart disease develops as a long-term complication of untreated or recurrent strep throat infections, highlighting the importance of early diagnosis and treatment of streptococcal infections to prevent severe heart damage. For instance, in April 2023, according to the Centers for Disease Control and Prevention, a US-based government department, strep throat accounts for an estimated 5.2 million outpatient visits annually among individuals younger than 65 years old. These visits lead to 2.8 million antibiotic prescriptions each year. Therefore, the increasing prevalence of strep throat is driving the growth of the rheumatic heart disease industry.

Key Players In The Global Rheumatic Heart Disease Market

Major companies operating in the rheumatic heart disease market are Pfizer Inc., Merck And Co Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, Medtronic plc, Siemens Healthineers AG, Becton Dickinson And Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta, Johnson And Johnson Services Inc., Roche Holding AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Boehringer Ingelheim International GmbH, Edwards Lifesciences Corporation

Global Rheumatic Heart Disease Market Trends and Insights

Major companies operating in the rheumatic heart disease market are adopting a strategic partnership approach to develop innovative treatments and diagnoses. Strategic partnerships in the rheumatic heart disease (RHD) management unite resources and expertise to advance research and development, enhance diagnostic and therapeutic innovations, expand market penetration, and fast-track commercialization. For instance, in July 2023, the World Heart Federation (WHF), a Switzerland-based non-governmental organization, partnered with the Philips Foundation, a Netherlands-based nonprofit organization, to improve awareness, medical training, and early detection of rheumatic heart disease (RHD) in the Asia-Pacific (APAC) region. Launched in the Philippines, the initiative seeks to enhance healthcare access for over half a million at-risk Filipino children by equipping facilities with trained professionals and advanced diagnostic tools. This collaboration underscores a joint commitment to strengthening healthcare infrastructure and ensuring timely intervention for RHD patients.

What Are Latest Mergers And Acquisitions In The Rheumatic Heart Disease Market?

In February 2025, Light AI Inc., a Canada-based healthcare technology company, partnered with MrBeast Industries to support global health initiatives. This collaboration focuses on donating AI-powered Strep A tests across Africa, enabling early detection and prevention of the disease to reduce the risk of severe complications such as rheumatic heart disease. MrBeast Industries is a US-based media and entertainment company that focuses on digital content creation.

Regional Outlook

North America was the largest region in the rheumatic heart disease market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rheumatic Heart Disease Market?

The rheumatic heart disease market consists of revenues earned by entities by providing services such as surgical treatments, diagnostic tests, preventive care services, and pediatric care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rheumatic heart disease market also includes sales of antibiotics, anti-inflammatory medications, diuretics, beta-blockers, and ACE inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rheumatic Heart Disease Market Report 2026?

The rheumatic heart disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rheumatic heart disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.